Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Sponsor: Viome
Summary
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Official title: Pilot Feasibility Study of the Interplay Between the Host Gut Microbiome and Efficacy of Treatment for Advanced or Recurrent Gynecological Cancer Patients Receiving Immunotherapy
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2021-06-29
Completion Date
2026-06
Last Updated
2025-01-29
Healthy Volunteers
No
Locations (1)
AdventHealth Cancer Institute
Orlando, Florida, United States